Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia (Q30858718)

18 August 2017

Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia (English)

1 reference

18 August 2017

1 reference

10

1 reference

PubMed publication ID

27 June 2017

Grazia Palomba

9

0 references

Marina Pisano

object named as

Marina Pisano

8

0 references

author name string

Mario Budroni

1

1 reference

18 August 2017

Rosaria Cesaraccio

2

1 reference

18 August 2017

Vincenzo Coviello

3

1 reference

18 August 2017

Ornelia Sechi

4

1 reference

18 August 2017

Daniela Pirino

5

1 reference

18 August 2017

Antonio Cossu

6

1 reference

18 August 2017

Francesco Tanda

7

1 reference

18 August 2017

language of work or name

English

0 references

publication date

20 February 2009

1 reference

18 August 2017

1 reference

18 August 2017

9

1 reference

18 August 2017

62

1 reference

Creative Commons Attribution 2.0 Generic

18 August 2017

start time

20 February 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Risk factors for the incidence of breast cancer: do they affect survival from the disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Screening for hereditary breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Breast cancer prognostication and prediction: are we making progress?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Origin and distribution of the BRCA2-8765delAG mutation in breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: a population-based study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Histopathology of BRCA1- and BRCA2-associated breast cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Survival and prognostic factors in BRCA1-associated breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Gene expression profiling predicts clinical outcome of breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Cancer survival corrected for heterogeneity in patient withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Age adjustment of cancer survival rates: methods, point estimates and standard errors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Survival and recurrence after breast cancer in BRCA1/2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Surveillance for familial breast cancer: Differences in outcome according toBRCA mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Spectrum and prevalence ofBRCA1 andBRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-9-62

Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2653541

Familial invasive breast cancers: worse outcome related to BRCA1 mutations

25 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19232099

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19232099

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19232099

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2407-9-62

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference

18 August 2017

PubMed publication ID

19232099

1 reference